These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29672108)

  • 1. A greater tendency for representation mediated learning in a ketamine mouse model of schizophrenia.
    Koh MT; Ahrens PS; Gallagher M
    Behav Neurosci; 2018 Apr; 132(2):106-113. PubMed ID: 29672108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
    Monte AS; de Souza GC; McIntyre RS; Soczynska JK; dos Santos JV; Cordeiro RC; Ribeiro BM; de Lucena DF; Vasconcelos SM; de Sousa FC; Carvalho AF; Macêdo DS
    J Psychopharmacol; 2013 Nov; 27(11):1032-43. PubMed ID: 24045882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
    Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
    Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
    da Silva Araújo T; Maia Chaves Filho AJ; Monte AS; Isabelle de Góis Queiroz A; Cordeiro RC; de Jesus Souza Machado M; de Freitas Lima R; Freitas de Lucena D; Maes M; Macêdo D
    J Psychiatr Res; 2017 Jan; 84():49-58. PubMed ID: 27697587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
    Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
    Ehrlichman RS; Gandal MJ; Maxwell CR; Lazarewicz MT; Finkel LH; Contreras D; Turetsky BI; Siegel SJ
    Neuroscience; 2009 Jan; 158(2):705-12. PubMed ID: 19015010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.
    Chatterjee M; Ganguly S; Srivastava M; Palit G
    Behav Brain Res; 2011 Jan; 216(1):247-54. PubMed ID: 20699106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kamin blocking is disrupted by low-dose ketamine in mice: Further implications for aberrant stimulus processing in schizophrenia.
    Suzuki R; Yamaguchi K; Kosaki Y
    Behav Neurosci; 2024 Feb; 138(1):30-42. PubMed ID: 37768591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.
    Koh MT; Shao Y; Rosenzweig-Lipson S; Gallagher M
    Schizophr Res; 2018 Mar; 193():119-125. PubMed ID: 28634087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.
    Meyer U; Spoerri E; Yee BK; Schwarz MJ; Feldon J
    Schizophr Bull; 2010 May; 36(3):607-23. PubMed ID: 18845557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine facilitates appetitive trace conditioning in mice: Further evidence for abnormal stimulus representation in schizophrenia model animals.
    Suzuki R; Kosaki Y
    Behav Neurosci; 2023 Aug; 137(4):236-253. PubMed ID: 37126024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice.
    Meyer U; Chang DL; Feldon J; Yee BK
    Neuropsychopharmacology; 2004 Dec; 29(12):2140-8. PubMed ID: 15238994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Reality Testing in Mice Through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli.
    Fry BR; Russell N; Gifford R; Robles CF; Manning CE; Sawa A; Niwa M; Johnson AW
    Schizophr Bull; 2020 Jan; 46(1):54-67. PubMed ID: 31150554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
    Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
    Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
    Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U
    Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
    Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
    Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Reality Testing in Mice Lacking Phospholipase Cβ1: Observed by Persistent Representation-Mediated Taste Aversion.
    Kim HJ; Koh HY
    PLoS One; 2016; 11(1):e0146376. PubMed ID: 26731530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
    Rogóż Z
    Pharmacol Rep; 2012; 64(6):1567-72. PubMed ID: 23406768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity.
    Vardigan JD; Lange HS; Tye SJ; Fox SV; Smith SM; Uslaner JM
    Psychopharmacology (Berl); 2016 Jul; 233(13):2441-50. PubMed ID: 27117142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
    Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.